1. Home
  2. SHLT vs CELU Comparison

SHLT vs CELU Comparison

Compare SHLT & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHLT
  • CELU
  • Stock Information
  • Founded
  • SHLT 1987
  • CELU 2016
  • Country
  • SHLT Israel
  • CELU United States
  • Employees
  • SHLT N/A
  • CELU N/A
  • Industry
  • SHLT Business Services
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • SHLT Consumer Discretionary
  • CELU Health Care
  • Exchange
  • SHLT Nasdaq
  • CELU Nasdaq
  • Market Cap
  • SHLT 39.3M
  • CELU 42.2M
  • IPO Year
  • SHLT N/A
  • CELU N/A
  • Fundamental
  • Price
  • SHLT $1.95
  • CELU $1.77
  • Analyst Decision
  • SHLT
  • CELU
  • Analyst Count
  • SHLT 0
  • CELU 0
  • Target Price
  • SHLT N/A
  • CELU N/A
  • AVG Volume (30 Days)
  • SHLT 7.1K
  • CELU 175.7K
  • Earning Date
  • SHLT 04-24-2025
  • CELU 12-06-2024
  • Dividend Yield
  • SHLT N/A
  • CELU N/A
  • EPS Growth
  • SHLT N/A
  • CELU N/A
  • EPS
  • SHLT N/A
  • CELU N/A
  • Revenue
  • SHLT $55,939,000.00
  • CELU $48,200,000.00
  • Revenue This Year
  • SHLT N/A
  • CELU N/A
  • Revenue Next Year
  • SHLT N/A
  • CELU $233.89
  • P/E Ratio
  • SHLT N/A
  • CELU N/A
  • Revenue Growth
  • SHLT N/A
  • CELU 225.94
  • 52 Week Low
  • SHLT $1.90
  • CELU $1.00
  • 52 Week High
  • SHLT $7.96
  • CELU $5.69
  • Technical
  • Relative Strength Index (RSI)
  • SHLT 33.24
  • CELU 51.89
  • Support Level
  • SHLT $2.30
  • CELU $1.47
  • Resistance Level
  • SHLT $2.54
  • CELU $2.40
  • Average True Range (ATR)
  • SHLT 0.23
  • CELU 0.21
  • MACD
  • SHLT -0.04
  • CELU 0.06
  • Stochastic Oscillator
  • SHLT 0.00
  • CELU 45.48

About SHLT SHL Telemedicine Ltd

SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

Share on Social Networks: